Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Fv-IgG)  (BSDG-126)

Recombinant Anti-CD64 x Anti-GD2 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD64 IgG with similar domains from an anti-GD2 antibody via short peptide linkers, or vice versa. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.

Datasheet